← Leaderboards
Ha Linh Vu
Thomas Jefferson University
$207,489
Attributed
$207,489
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $43.1K · FY2012–16$50K$37.5K$25K$12.5K$0
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$207,489 · 1
By mechanism
F31$207,489 · 1
Top collaborators
No co-investigators on record.
Most similar at Thomas Jefferson University
Same institution · by research overlap
- Dennis B Leeper$1,908,536
- Edward Hartsough$1,866,642
- Agnieszka Witkiewicz$7,548,076
- My Georgia Mahoney$4,406,462
- Sheera Rosenbaum$544,723
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisAccountingBraf GeneCancer CellCell DeathBaseCellsClinical EfficacyClinical TrialsCollagenCombined Modality TherapyCytotoxicDermalCell LineDoseEnvironmentExcisionFamily MemberFda ApprovedGenesGenotypeGrowthInhibitor/AntagonistIn Vitro
Grant awards (5)
Identifying novel therapeutic strategies in mutant NRAS melanoma$37,229
F31 · FY2016 · CA · contact PI
Identifying novel therapeutic strategies in mutant NRAS melanoma$43,120
F31 · FY2015 · CA · contact PI
Identifying novel therapeutic strategies in mutant NRAS melanoma$42,676
F31 · FY2014 · CA · contact PI
Identifying novel therapeutic strategies in mutant NRAS melanoma$42,232
F31 · FY2013 · CA · contact PI
Identifying novel therapeutic strategies in mutant NRAS melanoma$42,232
F31 · FY2012 · CA · contact PI